FTC Requires Asset Divestitures Before Allowing Boston Scientific�s $27 Billion Acquisition of Guidant Corporation: "The Federal Trade Commission today announced a consent agreement that will protect competition and consumers in several significant medical device markets affected by Boston Scientific�s proposed $27 billion acquisition of the Guidant Corporation (Guidant). The agreement will allow the transaction to proceed, provided the parties comply fully with its terms"
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment